A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy
Abstract Background The prevalence of esophageal stenosis caused by immune checkpoint inhibitors in the context of induced immune mucositis and esophagitis is extremely rare. Case presentation We report the case of a patient with stage IV pulmonary adenocarcinoma treated for 6 months with nivolumab...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2018-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-018-0481-0 |